16:17 EST Cartesian Therapeutics (RNAC) files to sell 11.39M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNAC:
- Cartesian Therapeutics files to sell 6.25M shares of common stock for holders
- Cartesian Therapeutics files $400M mixed securities shelf
- Cartesian Therapeutics price target raised to $45 from $41 at H.C. Wainwright
- Cartesian Therapeutics Reports Promising Phase 2b Trial Results
- Cartesian Therapeutics reports positive updated Phase 2b results in myasthenia